An Efficient Care Process for Your Heart Health
About ARSLON
Full-cycle care through 3-stage prediction (stenosis-eFFR-3VD), ArslonHeart-CAD package
Provides risk of coronary artery stenosis
Provide eFFR values
Provides location information of stenotic blood vessels
Used in routine ECG examinations during health screenings
and chronic disease management to support the early detection of
high-risk ischemic heart disease.
Provides estimated FFR (eFFR) values for patients with moderate
or higher stenosis risk,
supporting decisions on the need for additional testing
and appropriate treatment options.
In three-vessel disease (3VD),
where all three coronary arteries are obstructed, stent intervention is not feasible
and surgical treatment is required.
Early diagnosis is crucial to secure the critical window for surgery.
Establishing a more efficient treatment process by predicting with an artificial intelligence (AI) model.
Aslon predicts stenosis severity, eFFR, and the number of affected vessels,
enabling the establishment of a more efficient clinical care pathway.
ArslonHeart-CAD package
ArslonHeart-eFFR demonstration video
Contact
Headquarters: 2nd floor, 222, 80 Seonghyeon-ro, Gwanak-gu, Seoul (Gwanak Dream Town Apartment Complex)
Research Center: Room 507, Seoul Startup Hub M+, 14 Magokjungang 8-ro, Gangseo-gu, Seoul
Company: 5th floor, Chungnam Changupmaru Nabi, 48 Buldang 14-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do
02-877-2504
